옵션 체인은 다양한 행사가격과 만기일에 대한 Terran Orbital Corp Warrants (09/03/2028)의 주식 옵션 주요 데이터를 보여줍니다. 트레이더들은 이 정보를 사용하여 잠재적 거래를 분석하고 Terran Orbital Corp Warrants (09/03/2028)에 대한 시장 심리를 평가합니다..

Terran Orbital Corp Warrants (09/03/2028) (OTC:LLAPW) 주식, 옵션 체인

Terran Orbital Corp Warrants (09/03/2028)

Keefe, Bruyette &amp; Woods analyst Wood Lay maintains Five Star (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FSBC#NASDAQ">FSBC</a>) with a Market Perform and lowers the price target from $37 to $35.

News

Price Target

Analyst Ratings

FSBC

Keefe, Bruyette & Woods Maintains Market Perform on Five Star, Lowers Price Target to $35

JMP Securities analyst Karol Chmiel reiterates RenaissanceRe Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RNR#NYSE">RNR</a>) from Market Perform to Market Perform.

Reiteration

JMP Securities Reiterates Market Perform on RenaissanceRe Holdingsto Market Perform

Scotiabank analyst Nat Schindler maintains Meta Platforms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) with a Sector Perform and raises the price target from $583 to $627.

Scotiabank Maintains Sector Perform on Meta Platforms, Raises Price Target to $627

Keefe, Bruyette &amp; Woods analyst Damon Delmonte reiterates First Busey (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BUSE#NASDAQ">BUSE</a>) with a Outperform and lowers the price target from $34 to $33.

BUSE

Keefe, Bruyette & Woods Reiterates Outperform on First Busey, Lowers Price Target to $33

Keefe, Bruyette &amp; Woods analyst Christopher O'Connell maintains Blue Foundry (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLFY#NASDAQ">BLFY</a>) with a Market Perform and lowers the price target from $11 to $10.

BLFY

Keefe, Bruyette & Woods Maintains Market Perform on Blue Foundry, Lowers Price Target to $10

Guidance

Altria Ceo William Gifford Says Altria Disagrees With ITC Decision In Juul Patent Case, Sees Juul's Patents As Invalid

CoStar Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSGP#NASDAQ">CSGP</a>) has outperformed the market over the past 15 years by 9.86% on an annualized basis producing an average annual return of 22.09%. Currently, CoStar Gr has a market capitalization of $31.37 billion. 
Buying $1000 In CSGP: If an investor had bought $1000 of CSGP stock 15 years ago, it would be worth $20,096.81 today based on a price of $76.53 for CSGP at the time of writing.
<h3>CoStar Gr's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1738247411_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

CSGP

$1000 Invested In CoStar Gr 15 Years Ago Would Be Worth This Much Today

Keefe, Bruyette &amp; Woods analyst Christopher O'Connell maintains BCB Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BCBP#NASDAQ">BCBP</a>) with a Market Perform and lowers the price target from $15 to $13.75.

BCBP

Keefe, Bruyette & Woods Maintains Market Perform on BCB Bancorp, Lowers Price Target to $13.75

JMP Securities analyst Devin Ryan maintains Raymond James Finl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RJF#NYSE">RJF</a>) with a Market Outperform and raises the price target from $175 to $190.

JMP Securities Maintains Market Outperform on Raymond James Finl, Raises Price Target to $190

Keefe, Bruyette &amp; Woods analyst Catherine Mealor maintains Atlantic Union Bankshares (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AUB#NYSE">AUB</a>) with a Market Perform and lowers the price target from $46 to $44.

Keefe, Bruyette & Woods Maintains Market Perform on Atlantic Union Bankshares, Lowers Price Target to $44

WIIM

CELZ

Creative Medical Technology Holdings shares are trading higher after the company announced initial data from the first cohort of its ongoing Phase 1/2 clinical trial of CELZ-201-DDT.

JMP Securities analyst Trevor Walsh maintains Planet Labs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PL#NYSE">PL</a>) with a Market Outperform and raises the price target from $4.5 to $6.5.

JMP Securities Maintains Market Outperform on Planet Labs, Raises Price Target to $6.5

Biotech

General

Creative Medical Technology Holdings Announces Initial Safety, Tolerability, and Efficacy Data From First Cohort In Phase 1/2 Trial Of CELZ-201-DDT

HarborOne Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HONE#NASDAQ">HONE</a>) announced its Q4 earnings on Thursday, January 30, 2025 at 08:21 AM.
Here's a breakdown of the earnings report.
<h3>Earnings</h3>
HarborOne Bancorp beat estimated earnings by 24.0%, reporting an EPS of $0.21 versus an estimate of $0.17.
Revenue was down $6.77 million from the same period last year.
<h3>Historical Earnings Summary</h3>
In the previous quarter, the company missed on EPS by $0.09, resulting in a 0.0% increase change in the share price the following day.
Here's a look at HarborOne Bancorp's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.19</td>
<td>0.17</td>
<td>0.11</td>
<td>0.15</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.10</td>
<td>0.18</td>
<td>0.17</td>
<td>0.09</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>32.17M</td>
<td>30.78M</td>
<td>29.23M</td>
<td>30.24M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>31.89M</td>
<td>31.35M</td>
<td>30.58M</td>
<td>38.60M</td>
</tr>
</tbody>
</table>

 Listen to the earnings announcement yourself by <a href="">clicking here</a>. 
To track all earnings releases for HarborOne Bancorp <a href="https://www.benzinga.com/quote/HONE/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings

HONE

HarborOne Bancorp Earnings Review: Q4 Summary

Raymond James analyst Michael Rose maintains Veritex Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VBTX#NASDAQ">VBTX</a>) with a Strong Buy and lowers the price target from $32 to $31.

VBTX

Raymond James Maintains Strong Buy on Veritex Holdings, Lowers Price Target to $31

Red River Bancshares (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RRBI#NASDAQ">RRBI</a>) announced its Q4 earnings on Thursday, January 30, 2025 at 08:30 AM.
Here's a breakdown of the earnings report.
<h3>Earnings</h3>
Red River Bancshares beat estimated earnings by 10.0%, reporting an EPS of $1.37 versus an estimate of $1.24.
Revenue was up $2.20 million from the same period last year.
<h3>Performance in Previous Earnings</h3>
In the previous quarter, the company beat on EPS by $0.08, resulting in a 1.0% drop change in the share price the following day.
Here's a look at Red River Bancshares's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>1.19</td>
<td>1.10</td>
<td>1.03</td>
<td>0.98</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>1.27</td>
<td>1.16</td>
<td>1.16</td>
<td>1.16</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>22.47M</td>
<td>21.73M</td>
<td>23.57M</td>
<td>20.73M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>27.88M</td>
<td>26.89M</td>
<td>26.29M</td>
<td>26.48M</td>
</tr>
</tbody>
</table>

 Listen to the earnings announcement yourself by <a href="">clicking here</a>. 
To track all earnings releases for Red River Bancshares <a href="https://www.benzinga.com/quote/RRBI/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

RRBI

Red River Bancshares Earnings Report: Q4 Overview

JMP Securities analyst Patrick Walravens reiterates ServiceNow (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOW#NYSE">NOW</a>) with a Market Outperform and maintains $1300 price target.

JMP Securities Reiterates Market Outperform on ServiceNow, Maintains $1300 Price Target

Raymond James analyst Matt Roberts maintains Silgan Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLGN#NYSE">SLGN</a>) with a Outperform and raises the price target from $62 to $65.

SLGN

Raymond James Maintains Outperform on Silgan Hldgs, Raises Price Target to $65

Scotiabank analyst Ben Isaacson maintains Methanex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MEOH#NASDAQ">MEOH</a>) with a Sector Outperform and raises the price target from $60 to $66.

MEOH

Scotiabank Maintains Sector Outperform on Methanex, Raises Price Target to $66

Raymond James analyst Michael Rose reiterates Renasant (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RNST#NYSE">RNST</a>) with a Outperform and raises the price target from $40 to $44.

Comments

Terran Orbital Corp Warrants (09/03/2028)

Terran Orbital Corp Warrants (09/03/2028) (LLAPW) 옵션

No option chain data available. Please try again later

뉴스

파트너 / 기고자

벤징가 글로벌